According to Evoke Pharma 's latest financial reports the company's current EPS (TTM) is -$2.36. In 2022 the company made an earnings per share (EPS) of -$2.64 an increase over its 2021 EPS that were of -$3.15.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$2.36 | -10.61% |
2022 | -$2.64 | -16.19% |
2021 | -$3.15 | -49.52% |
2020 | -$6.24 | 57.58% |
2019 | -$3.96 | -28.26% |
2018 | -$5.52 | -45.24% |
2017 | -$10.08 | -33.86% |
2016 | -$15.24 | -32.8% |
2015 | -$22.68 | -13.7% |
2014 | -$26.28 | 65.26% |
2013 | -$15.90 | -25.35% |
2012 | -$21.30 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
ANI Pharmaceuticals ANIP | -$0.47 | -80.08% | ๐บ๐ธ USA |
Amphastar Pharmaceuticals AMPH | $2.10 | -188.98% | ๐บ๐ธ USA |
Aerie Pharmaceuticals AERI | -$0.75 | -68.22% | ๐บ๐ธ USA |
Ironwood Pharmaceuticals
IRWD | -$5.89 | 149.58% | ๐บ๐ธ USA |